Recent Articles from GlobeNewswire

Patent-pending platform is designed to connect genetic insights, personalized guidance and evolving information about a dog's wellness needs

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against EquipmentShare.com Inc. (NasdaqGS: EQPT) (“EquipmentShare” or the “Company”), if they purchased or otherwise acquired: (a) EquipmentShare.com, Inc. Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s January 2026 initial public offering (the “IPO”); and/or (b) EquipmentShare securities between January 23, 2026 and June 23, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against  Wix.com Ltd. (NasdaqGS: WIX) (“Wix” or the “Company”), if they purchased or otherwise acquired Wix securities between February 19, 2025 and May 12, 2026, inclusive (the “Class Period”).  This action is pending in the United States District Court for the Northern District of Illinois.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 30, 2026 to file lead plaintiff applications in a securities class action lawsuit against York Space Systems, Inc. (“York Space Systems” or the “Company”) (NYSE: YSS), if they purchased or otherwise acquired (a) York Space Systems common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 2026 initial public offering (“IPO” or the “Offering”); and/or (b) securities between January 29, 2026 and May 11, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Colorado.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against HDFC Bank Limited (“HDFC” or the “Company”) (NYSE: HDB), if they purchased HDFC securities between July 17, 2023 and May 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Primoris Services Corporation (NYSE: PRIM) (“Primoris” or the “Company”), if they purchased the Company’s shares between August 5, 2025 and June 22, 2026, both dates inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Texas.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Cogent Communications Holdings, Inc. (NasdaqGS: CCOI) (“Cogent” or the “Company”), if they purchased the Company’s shares between February 29, 2024 and May 1, 2026, inclusive (the “Class Period”).  This action is pending in the United States District Court for the District of Columbia.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation (NasdaqGM: PRCT) (“Procept” or the “Company”), if they purchased the Company’s shares between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Simply Good Foods Company (“Simply Good” or the “Company”) (NasdaqCM: SMPL), if they purchased Simply Good shares between October 24, 2024 and April 8, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR), if they purchased Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against AEVEX Corp. (“Aevex” or the “Company”) (NYSE: AVEX), if they purchased or otherwise acquired Aevex’s publicly traded Class A common stock between April 17, 2026 and June 4, 2026, inclusive (the “Class Period”) and/or pursuant or traceable to the registration statement and prospectus (the “IPO Offering Documents”) issued in connection with Aevex’s April 17, 2026 initial public offering (“IPO”). This action is pending in the United States District Court for the Southern District of California.

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 29, 2026 to file lead plaintiff applications in a securities class action lawsuit against  Avis Budget Group, Inc. (“Avis” or the “Company”) (NasdaqGS: CAR), if they purchased or otherwise acquired Avis securities (including those who bought Avis common stock to cover a short position) between February 20, 2025 and April 21, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Florida.

Diversified Announces Accretive Acquisition of Birch

New capability allows casino resorts to evaluate player activity and run marketing programs based on complete trips, not only individual visits

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026

Strategic agreement pairs Patton's industrial networking and cybersecurity technology with alfanar's energy-infrastructure expertise to modernize smart-grid and substation operations across Saudi Arabia

MELVILLE, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (Nasdaq: BRTX) (“BioRestorative” or the “Company”), a late-stage clinical regenerative medicine company, today announced that the Company’s Board of Directors approved a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock (the “Common Stock”). The Company was not required to obtain stockholder approval to effectuate the Reverse Stock Split under Nevada law. The Company filed a certificate of change with the Secretary of State of the State of Nevada, which is expected to become effective as of 4:30 P.M. Eastern Time on September 7, 2026. The Common Stock will begin trading on The Nasdaq Capital Market on a reverse split-adjusted basis at the start of trading on September 8, 2026, under the symbol “BRTX” and under a new CUSIP number, 090655705. The Company is effecting the Reverse Stock Split with the intention of regaining compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).

DALLAS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced an amendment to its senior secured credit facility (the “Corporate Credit Facility”). The amendment (a) increased commitments under the Corporate Credit Facility from $510 million to $595 million, (b) decreased the applicable margin from 2.15% to 2.00%, (c) removed the SOFR adjustment, (d) increased the uncommitted accordion feature that could increase the maximum commitments from $750 million to $1 billion, (e) reduced the unused commitment fees from a range of (i) 0.50%-1.00% to (ii) 0.50%-0.75% per annum, based on utilization, on the unused lender commitments, and (f) amended certain financial covenants. In addition, the end of the Corporate Credit Facility’s revolving period was extended from August 2, 2027 to September 2, 2030, and the final maturity was extended from August 2, 2028 to September 2, 2031.

The Largest Evening Parade in the U.S. Kicks Off the Holiday Season in Chicago on Nov. 21

OLIVE TREE PEOPLE opens first U.S. flagship store – “a cathedral to Waterless Beauty” - on Abbot Kinney in Los Angeles

CLAYMONT, Del., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Archimedes Tech SPAC Partners II Co. (Nasdaq: ATII), a publicly traded special purpose acquisition company (“ATII” or “Archimedes II”), today announced the filing with the U.S. Securities and Exchange Commission (the “SEC”), on September 2, 2026, of an amendment to the registration statement on Form S-4 (File No.: 333-295563) (as may be amended from time to time, the “Registration Statement”) previously filed in connection with the previously announced proposed business combination with Forge Nano, Inc. (“Forge Nano”). The Registration Statement includes a preliminary proxy statement/prospectus and has not yet been declared effective. The Registration Statement was filed by ATII Holdings Inc. (CIK 0002101833), ATII’s wholly-owned subsidiary (“Pubco”), and Forge Nano (CIK 0001719324) and is available free of charge at the SEC’s web site at www.sec.gov.

NEW YORK and WALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on September 1, 2026, to four newly-hired, non-executive employees. The inducement grants were approved by the Company's independent Compensation Committee and were made as material inducements to acceptance of employment with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4).

PLYMOUTH, Mich. and ROLLE, Switzerland, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Garrett Motion Inc. (Nasdaq: GTX) ("Garrett" or the "Company"), a global leader in differentiated turbocharging and electrification technologies for mobility and industrial applications, today announced its participation in the upcoming investor conference:

Combined company pairs elite “white hat” hackers with agentic AI to deliver security validation at scale

Calgary, September 2, 2026 − Shell plc has completed the previously announced agreement (the “Arrangement Agreement”) to acquire ARC Resources Ltd. (“ARC”) (TSX: ARX), an energy company focused in British Columbia and Alberta, Canada, following receipt of all required shareholder, court and regulatory approvals. The acquisition accelerates Shell's strategy by adding approximately 370 kboe/d immediately across liquids and gas, supporting a production compound annual growth rate (CAGR) of around 4% through to 2030 compared with 2025.

TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Sprott Focus Trust, Inc. (Nasdaq-FUND) (the “Fund” or “FUND”) has declared a quarterly distribution of $0.1503 per share on its Common Stock. The distribution, optionally payable in additional shares of Common Stock or in cash by specific stockholder election, is to be paid on September 29, 2026 to stockholders of record at the close of business on September 15, 2026 (ex-dividend on September 15, 2026). The price of shares issued for reinvestment will be determined on September 22, 2026.

Toronto, Ontario, Canada, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Fort Technology Inc. (NASDAQ: FRTT; TSXV: FORT) (“Fort” or the “Company”), today announces that it has granted an aggregate of 102,857 restricted share units ("RSUs") pursuant to the Company's "fixed 20%" Omnibus Equity Incentive Plan (the "Plan"). The Plan received shareholder approval on August 21, 2025, and TSX Venture Exchange approval on August 27, 2025.

SAN JOSE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Zoom announced today the appointment of Jeff Epstein to its Board of Directors, effective immediately. Jeff previously served as EVP and CFO of Oracle and is currently an Operating Partner at Bessemer Venture Partners, a venture capital and private equity firm.

ROCKVILLE, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that management will participate in the following September investor conferences:

BEIJING, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Baosheng Media Group Holdings Limited (NASDAQ: BAOS) (“Baosheng Group” or the “Company”) today announced that its board of directors (the “Board”) has unanimously approved, by written resolutions dated September 1, 2026, to postpone the Company’s extraordinary general meeting of shareholders previously scheduled for September 4, 2026 (the “EGM”) indefinitely.

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 61,365 restricted stock units (“RSUs”) and options to purchase 19,425 shares of the Company’s common stock to eight newly-hired non-executive employees under the Company’s 2025 Inducement Equity Plan (the “Inducement Plan”), effective as of September 1, 2026. The options have an exercise price of $7.07 per share, which is equal to the closing price of the Company's common stock on August 31, 2026. The inducement grants were previously approved by the Compensation Committee of the Company’s Board of Directors, as a material inducement to the new employees’ entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that, in connection with the appointment of Jason V. O’Byrne as Chief Financial Officer effective August 11, 2026, the Company granted Mr. O’Byrne an employment inducement award consisting of stock options to purchase 650,000 shares of the Company’s common stock, with an effective grant date of September 1, 2026 and an exercise price of $10.56 per share, equal to the last reported sale price of the Company's common stock as reported by Nasdaq on September 1, 2026. The award was approved by the Compensation Committee of Olema’s Board of Directors and granted under the Company's 2022 Inducement Plan. The stock options vest over four years, with 25 percent vesting on August 11, 2027 and the remainder vesting in 36 equal monthly installments over the following three years, subject to continuous employment as of such vesting dates.

WALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that, effective September 1, 2026, the company granted non-qualified stock options to purchase 19,865 shares of its common stock to two new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan.

SAKHIR, Kingdom of Bahrain, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Her Excellency Fatima bint Jaafar Al Sairafi, Minister of Tourism of the Kingdom of Bahrain, received Chris Skeith OBE, CEO and Managing Director of the Global Association of the Exhibition Industry (UFI), Said Al Shanfari, UFI President-elect for the 2027-2028 term and CEO of the Oman Convention and Exhibition Centre (OCEC), and Naji El Haddad, UFI Regional Director for the Middle East and Africa, during their visit to the Kingdom of Bahrain to review preparations for the 93rd UFI Global Congress, which will take place in Bahrain this November.

MINNEAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), a leading vertically integrated cannabis company and agricultural markets platform, today announced that it will attend the following conference:

ISSAQUAH, Wash., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $23.70 billion for the retail month of August, the four weeks ended August 30, 2026, an increase of 9.9 percent from $21.56 billion last year.

Landmark international milestone unlocks significant new markets and broadens Flyte’s addressable aviation footprint beyond the United StatesNew capabilities connect Flyte’s growing Florida network with high-demand leisure and resort destinations throughout The Bahamas and Caribbean

CANTON, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated-commerce specialty retailer of Big + Tall men’s clothing and footwear, today announced the appointment of James E. “Jimmy” Olsson as Executive Vice President, Chief Growth Officer.

VALENCIA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that its senior management will participate in the following investor conferences:

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:

Daix (France), New York (New York, United States), September 2nd, 2026 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral small molecule therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the last patient has completed their final 72-week visit in the NATiV3 Phase 3 clinical trial evaluating lanifibranor for the treatment of patients with MASH with moderate and advanced fibrosis.

REGULATED INFORMATION INSIDE INFORMATION

AUSTIN, Texas and DURHAM, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potential first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced that company management will present at and participate in the following upcoming investor conferences:

MCLEAN, Va., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced that Serge Tanjga, Chief Financial Officer, will present at Citi’s Global TMT Conference in New York City.

ATLANTA, Sept. 02, 2026 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a global software and data company, today announced the Company’s management team will participate in the following upcoming investor conferences:

BANNOCKBURN, Ill., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced that John Rademacher, CEO and Meenal Sethna, CFO, will participate in the following up coming investor conferences:

NEW HOPE, Pa., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, reported today that, on September 1, 2026, the Compensation Committee of the Orchestra BioMed Board of Directors granted stock options to purchase an aggregate of 133,000 shares of the Company’s common stock to seven newly hired employees. The awards were granted pursuant to the Orchestra Biomed Holdings, Inc. 2025 New Hire Inducement Plan as an inducement material to each new employee entering employment with Orchestra Biomed, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options granted to each new employee will vest over a four-year period.

MINNEAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) --  SPS Commerce, Inc. (NASDAQ: SPSC), the leading intelligent supply chain network, today announced that management will present at Citi's 2026 Global TMT Conference on Wednesday, September 9, 2026, at 8:50 AM E.T.

SANTA CLARA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Netskope, Inc. (NASDAQ: NTSK) a leader in modern security and networking for the cloud and AI era, today announced financial results for the second quarter of fiscal year 2027 ended July 31, 2026.

WILMINGTON, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the platform for agentic AI banking, today announced its participation in the following investor conference:

ST. PETERSBURG, Fla., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Chairman and Chief Executive Officer, Michael Benstock, and President and Chief Financial Officer, Mike Koempel, will participate in both the Northcoast Research Virtual Conference on Wednesday, September 9, 2026, and the Sidoti Virtual Conference on Wednesday, September 23, 2026. Management will host virtual investor meetings each day in addition to participating in a fireside chat at the Sidoti event.

Initiated the first-in-human Phase 1 trial of STX-1150, a novel LDL-C lowering therapy powered by ELXR, a highly engineered epigenetic silencing technology designed to deliver ultra-long-acting cholesterol lowering without permanent genetic changes

ATTO-1310 demonstrated preliminary clinical proof of concept in chronic pruritus and high-itch atopic dermatitis (AD); complete Phase 1b data expected in Q4 2026

EMERYVILLE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical immunology company pioneering transformative therapies for people with neurologic autoimmune diseases, today announced that company management will present at the following upcoming conferences:

MENLO PARK, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will be participating in the upcoming Goldman Sachs Communacopia + Technology Conference on Wednesday, September 9, 2026.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance, today announced that management will be participating in the following investor conferences in September:

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of inducement equity awards to six newly hired non-executive employees as a material inducement to commencing their employment with the Company.

Phase 3 Aspire did not achieve the primary endpoint of change from Baseline in Bayley-4 cognitive raw score nor the key secondary endpoint of net response in Multidomain Responder Index (MDRI)

CAMBRIDGE, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, including silevertinib, a potential best-in-class brain-penetrant epidermal growth factor receptor (EGFR) inhibitor, today announced that its Chief Scientific Officer, Elizabeth Buck, Ph.D., will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026, in New York, NY. In addition, the Company will host one-on-one meetings with investors on the same day.

NEWTON, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in the following upcoming investor conferences.

New flagship reasoning model strengthens Europe’s sovereign AI capability, combining a score of 43 with a 15.3-second response time for enterprise agents and coding

Central New Mexico Community College, the City of Albuquerque, and the New Mexico Economic Development Department unveil a state-of-the-art facility for careers in the creative industries.

SHANGHAI, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Six Degrees Intelligence, a leading qualitative research platform in China, is pleased to announce a content collaboration with S&P Global Market Intelligence. Under the arrangement, Six Degrees’ research content will be made available to S&P Global Market Intelligence clients via Capital IQ Pro.

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) between August 4, 2025 and July 29, 2026, inclusive.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In EyePoint (EYPT) To Contact Him Directly To Discuss Their Options

AUSTIN, Texas, Sept. 02, 2026 (GLOBE NEWSWIRE) -- The National Domestic Violence Hotline (The Hotline) answered its 8 millionth contact on July 29 at 11:43 a.m. CT, marking a milestone that reflects both three decades of support for survivors and the growing demand for domestic violence services.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sionna Therapeutics (SION) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In UWM To Contact Him Directly To Discuss Their Options

BREWSTER, Wash., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Brewster Heights Orchard & Packing (BHPO) and Heritage Orchard Alliance (HOA) have announced an important milestone in BHPO’s Chapter 11 restructuring process following the resolution of a key prerequisite to the stalking horse transaction with HOA, the acquisition entity. HOA and The Prudential Insurance Company of America (Prudential), a major BHPO creditor, have reached an agreement, clearing the way for the transaction to advance.

LAKE FOREST, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Del Taco, the nation’s second-largest Mexican quick service restaurant*, is expanding its catering business beginning Thursday, September 3. The initiative is the latest Project Del Sunrise milepost and provides guests with a more direct way to place Del Taco catering orders. The program also introduces Taco Salads to the catering menu and folds the brand seamlessly into workplace lunches, meetings, celebrations and other group occasions. Project Del Sunrise was announced earlier this year as a strategic roadmap to strengthen restaurant performance, expand guest occasions and drive long-term growth.

WASHINGTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Associated Builders and Contractors today celebrated the release of Multiskilling in the U.S. Construction Industry, the largest national dataset documenting the relationship between multiskilling labor strategies and performance outcomes, including productivity, staffing levels and schedule durations. Among other findings, the research showed that multiskilling increased the share of crew time spent on directly advancing construction work by 39%.

Bipartisan legislation passes in unanimous vote

Free music-to-music technology platform adds faster generation, real-time mixing, and stem export while expanding Industry collaborations and its Creator-First approach

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hyliion (HYLN) To Contact Him Directly To Discuss Their Options

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the “Class Period”).